Group of supply chain employees

Sustainable Supply Chain

A Strategic Approach

To guide our work, we use a strategic quality process to prioritise, execute and monitor manufacturing and supply chain efforts across the globe. The process enables our teams to work toward a common set of objectives, including sustainability metrics. It’s how we propelled our construction of LEED-certified facilities from Massachusetts to Malaysia to Costa Rica and beyond.

Nurturing a Diverse Supply Chain

To meet the unique needs of 30 million patients each year, we need a wide variety of perspectives. Our products help patients from a diverse array of backgrounds, races and cultures. It’s only fitting that our suppliers should also reflect the diverse groups of patients that we serve.

Keeping our supply chain resilient and reliable

To ensure we are able to deliver for the more than 33 million patients annually who rely on our life-changing technology, our end-to-end global supply chain organisation is supported by an agile network adept at continuously responding to changing market conditions globally through supplier, manufacturing and distribution strategies. Our global supply chain network spans 15 principal manufacturing facilities including three facilities at Cork, Clonmel and Galway in Ireland, as well as various distribution, customer fulfillment and technology centres around the world.

Investing in a sustainable infrastructure

At Boston Scientific, we are continually investing in our facilities to improve energy efficiencies, reduce our carbon footprint and support employee well-being.

boston scientific clonmel

Boston Scientific Announces €80M Investment and 400+ Jobs at Clonmel Site

Boston Scientific Corporation (NYSE: BSX) announced an €80 million investment in its Clonmel operations at an event celebrating the site’s 25th anniversary with Taoiseach Leo Varadkar. The funding, supported by the Irish government through IDA Ireland, will go towards the continued expansion of the company’s medical technology manufacturing and research and development (R&D) capabilities and is expected to enable 400+ jobs in the coming years. Read More

boston scientific galway

Boston Scientific announces €100m investment in Galway Campus

Boston Scientific Corporation (NYSE: BSX) - a global leader in medical device technology – unveiled a new €100 million expansion of its operations at Ballybrit in Galway. The expansion is expected to enable 300+ jobs in the coming years and includes over 40,000 square feet of medical device manufacturing space that will be powered by renewable energy. Read More